Andrew C Seger
Overview
Explore the profile of Andrew C Seger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ismail S, Al-Subhi A, Youssif E, Ahmed M, Almalki A, Seger D, et al.
BMC Nephrol
. 2019 Nov;
20(1):408.
PMID: 31722680
Background: Nonadherence to medications by patients requiring hemodialysis (HD) leads to unfavorable clinical outcomes. Limited data exist to demonstrate the effect of incorporating patient-centered interventions using concepts of medication therapy...
2.
Slight S, Eguale T, Amato M, Seger A, Whitney D, Bates D, et al.
J Am Med Inform Assoc
. 2015 Nov;
23(2):311-6.
PMID: 26568606
Objective: To test the vulnerabilities of a wide range of computerized physician order entry (CPOE) systems to different types of medication errors, and develop a more comprehensive qualitative understanding of...
3.
Overhage J, Gandhi T, Hope C, Seger A, Murray M, Orav E, et al.
J Patient Saf
. 2015 May;
12(2):69-74.
PMID: 26001546
Background: Adverse drug events (ADEs) represent a significant cause of injury in the ambulatory care setting. Computerized physician order entry reduces rates of serious medication errors that can lead to...
4.
Seger A, Churchill W, Keohane C, Belisle C, Wong S, Sylvester K, et al.
J Oncol Pract
. 2013 Apr;
8(6):344-9, 1 p following 349.
PMID: 23598843
Purpose: Antineoplastic preparation presents unique safety concerns and consumes significant pharmacy staff time and costs. Robotic antineoplastic and adjuvant medication compounding may provide incremental safety and efficiency advantages compared with...
5.
Piazza G, Rao A, Nguyen T, Seger A, Hohlfelder B, Fanikos J, et al.
Clin Appl Thromb Hemost
. 2013 Mar;
19(5):469-75.
PMID: 23482721
Venous thromboembolism (VTE) is a common complication of cancer and chemotherapy. We evaluated the baseline clinical characteristics, thromboprophylaxis patterns, frequency and timing of VTE, and clinical outcomes in 1000 adult...
6.
Fanikos J, Rao A, Seger A, Carter D, Piazza G, Goldhaber S
Am J Med
. 2013 Jan;
126(2):127-32.
PMID: 23331440
Objective: Pulmonary embolism places a heavy economic burden on health care systems, but the components of hospital cost have not been elucidated. We evaluated hospitalized patients with the primary diagnosis...
7.
Gilbar P, Seger A
Asia Pac J Clin Oncol
. 2012 Nov;
9(3):290-1.
PMID: 23176407
No abstract available.
8.
9.
Gilbar P, Seger A
J Oncol Pharm Pract
. 2012 Jul;
18(3):377-8.
PMID: 22801956
Medication errors due to the inadvertent intrathecal administration of vincristine and other antineoplastic agents continue to occur despite the development of preventative strategies. Three fatalities due to bortezomib being accidentally...
10.
Abramson E, Bates D, Jenter C, Volk L, Barron Y, Quaresimo J, et al.
J Am Med Inform Assoc
. 2011 Dec;
19(4):644-8.
PMID: 22140209
Objective: Little is known about the frequency and types of prescribing errors in the ambulatory setting among community-based, primary care providers. Therefore, the rates and types of prescribing errors were...